Roll-Up Strategy in Private Equity: Buy-and-Build Explained

Introduction

If you spend any time around private equity today, one strategy comes up more than any other. It is not the headline-grabbing take-private of a public company, and it is not the distressed turnaround. It is the quiet, methodical work of buying one decent company and then bolting dozens of smaller ones onto it until the combined business is several times the size it started. This is the roll-up, also known as buy-and-build, and it has become the dominant value-creation playbook in the mid-market.

The scale of the shift is striking. Add-on acquisitions, the small follow-on deals that drive a roll-up, now account for roughly three quarters of all US private equity buyouts by deal count, up sharply over the past decade. Whole sectors that used to be made up of thousands of independent family businesses, from heating and air-conditioning contractors to accounting firms to veterinary clinics, are being stitched together into national platforms backed by some of the largest sponsors in the world.

This post explains how the strategy actually works: what a platform is and how it differs from an add-on, the multiple arbitrage math that makes the whole thing pay, the other levers that create value, why the model took over the mid-market, the sectors where it thrives, the full life cycle of a roll-up, and the very real ways these deals go wrong. We use real, recent examples throughout. If you want the foundation first, our explainer on the private equity fund structure covers the GP and LP relationship that all of this sits on top of.

A roll-up is a growth strategy built on acquisition rather than organic expansion. Instead of growing one company by winning more customers, a private equity firm grows it by buying other companies and merging them in. The thesis is consolidation: take a fragmented industry full of small, independently owned operators and combine many of them into a single larger business that is worth more as a whole than the sum of its parts.

"Roll-up" and "buy-and-build" describe the same idea, with a slight difference in emphasis. Roll-up tends to stress the consolidation angle, the act of rolling many small companies into one. Buy-and-build stresses the value creation, the idea that you buy a base and then build on it. In practice bankers and investors use the terms interchangeably, and you should treat them as synonyms in an interview.

Roll-Up (Buy-and-Build) Strategy

A private equity value-creation strategy in which a firm acquires one larger company to serve as a base, then makes a series of smaller acquisitions in the same industry and integrates them into that base. The goal is to build a single, larger, more valuable business from many fragmented operators and sell it at a higher valuation multiple than the individual companies were bought for.

The model works best in industries that are highly fragmented, meaning no single player dominates and the market is split across many small operators. Think of the thousands of local HVAC contractors, dental practices, or independent insurance brokers across the country. Each one is too small to attract a large buyer or command a premium valuation on its own. But assemble two hundred of them under one brand, one back office, and one management team, and you have created something a strategic acquirer or public market would pay a real premium to own.

Every roll-up is built from two kinds of acquisition, and understanding the difference is the single most important concept here. The first deal is the platform. Every deal after that is an add-on.

The platform company is the foundation. It is usually the largest acquisition in the whole program, and the sponsor pays the most attention to it, because everything else gets built on top of it. A good platform has a capable management team, systems that can scale, a recognizable brand or strong regional position, and enough size to absorb smaller businesses without choking. The sponsor typically pays a full multiple for the platform precisely because it is buying a base it can grow, not just a single company.

Platform Company

The initial, anchor acquisition in a roll-up. It is the larger, well-run business that provides the management team, systems, brand, and infrastructure onto which a private equity firm bolts smaller add-on acquisitions. The platform sets the strategy and absorbs the companies acquired after it.

Add-ons, sometimes called bolt-ons, are the smaller companies acquired after the platform and folded into it. These are where the strategy does its real work. Because add-ons are small and often have no other obvious buyer, the sponsor can usually acquire them at a much lower multiple than it paid for the platform. Each one brings extra revenue, extra earnings, new customers or new geographies, and once integrated, its profits get valued at the platform's higher multiple rather than its own. A single roll-up can involve dozens of add-ons over a hold period.

Here is how the two roles compare side by side:

Add-On (Bolt-On) Acquisition

A smaller company acquired after the platform and integrated into it as part of a roll-up. Add-ons are typically bought at lower valuation multiples than the platform, then re-valued at the platform's higher multiple once combined. They add scale, capabilities, customers, or geographic reach to the existing platform.

The relationship between the two is what makes the strategy work. The platform provides the multiple, the management, and the integration machine. The add-ons provide cheap earnings that get re-rated upward the moment they join. Get the platform wrong and the add-ons have nothing solid to attach to. Buy good add-ons and integrate them well, and the platform compounds in value faster than any single company could grow on its own.

The financial heart of a roll-up is multiple arbitrage, sometimes called multiple expansion through M&A. It sounds technical, but the idea is simple: buy earnings cheaply in small pieces, then sell them expensively as one big piece.

Valuations in private markets scale with size. A small business doing $1 million of EBITDA might sell for four or five times earnings, because it is risky, dependent on its owner, and has few potential buyers. A large, professionalized business doing $30 million of EBITDA in the same industry might trade at ten or eleven times earnings, because it is diversified, has real management depth, and attracts both strategic buyers and the public market. The roll-up exploits exactly this gap. If you can buy the small companies at five times and sell the combined entity at eleven times, you capture the difference on every dollar of acquired earnings.

Multiple Arbitrage

In a roll-up, the value created by acquiring smaller companies at low valuation multiples and selling the combined, larger business at a higher multiple. Because a bigger and more professional company commands a premium valuation, each dollar of earnings bought cheaply in a small add-on is worth more once it sits inside the larger platform.

A simplified example makes the mechanics concrete. Suppose a sponsor buys a platform with $10 million of EBITDA at a multiple of 8x, paying $80 million in enterprise value. Over the next four years it acquires a series of add-ons that together contribute another $10 million of EBITDA, bought at an average of just 5x, for a total of $50 million. The sponsor has now assembled a business with $20 million of combined EBITDA for $130 million of total acquisition cost, a blended entry multiple of about 6.5x.

At exit, the company is twice the size, diversified across more customers and locations, and run by a professional management team. A buyer values it at 11x. The exit enterprise value is:

Before any leverage or organic growth, the value created is $220 million minus $130 million, or $90 million. You can isolate the portion that comes purely from re-rating the cheaply bought add-ons:

This is why sponsors are willing to run aggressive acquisition programs. Every add-on bought below the eventual exit multiple is immediately value-accretive in theory, before integration even begins. The catch, which we return to later, is that the arbitrage only holds if you actually buy cheap, integrate well, and exit at the higher multiple. None of those is guaranteed. To go deeper on how multiples are derived and compared, see our guide to common valuation multiples.

Multiple arbitrage gets the headlines, but a well-run roll-up creates value in several other ways at the same time. Treating arbitrage as the only driver is a common interview mistake.

Cost and Revenue Synergies

The most important additional lever is synergies. When you combine many small companies, you can strip out duplicated overhead and gain real purchasing power. Each acquired business no longer needs its own bookkeeper, HR function, marketing budget, or back-office software. A single shared services center can run all of them. Combined, the platform buys equipment, supplies, and insurance at volume discounts no individual operator could negotiate. There are revenue synergies too: cross-selling services across a wider customer base, sharing leads between locations, and winning larger contracts that a small operator could never service. Our explainer on revenue versus cost synergies in M&A breaks down how these are estimated and where they tend to disappoint.

Operational Professionalization

A second lever is operational professionalization. Many add-on targets are owner-operated businesses with no formal financial reporting, inconsistent pricing, and no growth playbook. The platform installs proper systems: standardized pricing, professional management, KPI tracking, centralized procurement, and modern technology. This raises the margin of each acquired business and makes the whole group more attractive to a future buyer.

Leverage and Cheaper Capital

The third lever is leverage, the L in LBO. Like most private equity deals, roll-ups are funded partly with debt, and as the platform grows and pays that debt down, equity value compounds. A larger, more diversified platform can also support more debt on better terms than any single add-on could, which lowers the cost of capital for the whole program. If you are shaky on how debt magnifies equity returns, our LBO modeling guide walks through the mechanics step by step.

Accelerated Organic Growth

Finally there is accelerated organic growth. A small business under a national brand, with real marketing budgets and a wider service menu, often grows faster than it ever could alone. The best roll-ups do not just consolidate a static market; they take share within it.

Buy-and-build is not new, but its dominance is. A decade ago add-ons were around 60% of US buyout deal count; today they account for roughly three quarters, and the large majority of those platforms pursue multiple add-ons rather than a single bolt-on. Among the broader research on private equity strategy, Bain's Global Private Equity Report has tracked how central this consolidation model has become to how sponsors generate returns. Three forces drove the shift.

Expensive Platforms Need Cheap Add-Ons

The first force is valuation entry points. Platform companies in popular sectors became expensive, so paying a high multiple only made sense if you could blend it down with cheaper add-ons afterward. If you buy the platform at 12x but pull the blended cost of the whole program down to 8x with a series of 5x and 6x add-ons, the full platform price suddenly makes sense. Buy-and-build became the way to justify paying up for a quality base.

Deeply Fragmented Industries

The second force is the sheer fragmentation of large, unglamorous service industries. The United States has tens of thousands of independent contractors, clinics, and local service firms, many owned by founders nearing retirement with no succession plan, which creates a deep and motivated supply of sellers.

Operational Alpha Replaced Financial Engineering

The third force is operational alpha. As cheap debt disappeared in the higher-rate environment of recent years, sponsors could no longer rely on leverage and rising multiples alone to drive returns. Building something genuinely larger and better, through consolidation and operational improvement, became one of the few reliable ways to create value when financial engineering stopped doing the work for you. It is worth noting the other side of this: higher financing costs have also made some add-ons harder to fund, and the share of buyout activity by dollar value tied to add-ons has come down from its peak even as the deal-count share stayed high. The strategy did not stop; it got more disciplined.

The strategy is not for every industry. The best roll-up targets share a recognizable profile: a fragmented market, recurring or repeat revenue, low technological disruption risk, the ability to centralize back-office functions, and a long tail of small sellers. The clearest way to see how the model plays out is to trace real programs from the platform deal through the add-ons to the exit. Here are five, across very different industries.

Restaurants: Roark Capital Builds Inspire Brands

The Atlanta private equity firm Roark Capital, which specializes in franchised businesses, turned the roast-beef chain Arby's into the platform for one of the largest restaurant companies in America. In February 2018, the Roark-backed Arby's group acquired Buffalo Wild Wings for roughly $2.9 billion and renamed the combined holding company Inspire Brands. That was the platform. The add-ons came fast: Sonic Drive-In for about $2.3 billion later in 2018, Jimmy John's in 2019, and then the big one, Dunkin' Brands (which brought Baskin-Robbins with it) for roughly $11.3 billion in 2020.

The result is a multi-brand platform of more than 33,000 restaurants generating over $33 billion in annual system sales, with shared loyalty, data, and supply-chain infrastructure that no single chain could have built alone. The exit is now in motion: Inspire Brands confidentially filed for an initial public offering in May 2026, with Roark reportedly seeking a valuation of around $20 billion, which would let it cash out the consolidation thesis on the public market.

Insurance: GTCR and Apax Build (and Sell) AssuredPartners

If you want the textbook roll-up, this is it. Private equity firm GTCR formed AssuredPartners in 2011 specifically to consolidate the fragmented middle-market insurance brokerage industry. In its first four years GTCR completed roughly 112 acquisitions and grew annualized revenue past $500 million. In 2015 it sold a majority stake to Apax Partners, which kept the machine running with around 124 more acquisitions. GTCR then returned in 2019 in a deal that valued the broker at about $5.1 billion including debt, and kept buying. Over roughly 13 years the platform acquired and integrated more than 500 businesses, reaching about 400 offices and $2.9 billion of revenue.

The exit was the payoff. In December 2024, GTCR and Apax agreed to sell AssuredPartners to strategic acquirer Arthur J. Gallagher for $13.45 billion in cash, a deal that closed in 2025 and stands as the largest sale of a US insurance broker to a strategic buyer in history, as set out in Gallagher's own deal disclosure.

Veterinary Care: Ares Builds NVA, JAB Buys It

Veterinary medicine became one of the hottest roll-up arenas of the last decade. Ares Management, alongside Canadian pension investor OMERS, built National Veterinary Associates (NVA) into one of the largest vet-care organizations in the world, partnering with more than 700 hospitals and pet resorts spanning general practice, specialty and emergency care, and equine medicine across the US, Canada, Australia, and New Zealand. In June 2019 Ares and OMERS sold NVA to JAB Holding, the family-backed group behind Panera and Krispy Kreme, which had entered pet care just months earlier by buying Compassion-First Pet Hospitals for $1.2 billion.

The sector context shows both the appeal and the danger. Mars had already bought the public vet-hospital roll-up VCA for $9.1 billion in 2017, and the competition for independent clinics grew so fierce that practice valuations that once sat at a few times annual earnings were bid up into the double digits, by some reports as high as thirty times. When that many consolidators chase the same targets, the cheap end of the arbitrage simply disappears.

Home Services: Alpine Investors and the Apex Machine

For a roll-up still in full flight, look at Apex Service Partners, founded by Alpine Investors in 2019 and built on two Florida home-services businesses, Frank Gay Services and Best Home Services. From that base, Apex became one of the largest consolidators of HVAC, plumbing, and electrical contractors in the country, a national platform employing more than 8,000 people.

Rather than sell outright, Alpine ran a $3.4 billion single-asset continuation fund in October 2023, one of the largest deals of its kind, with its own Fund IX committing $450 million alongside secondary investors including Blackstone Strategic Partners, HarbourVest, Lexington Partners, and Pantheon. That structure let Alpine return capital to its earlier investors while holding onto a winning platform, a route covered in our explainer on continuation vehicles and GP-led secondaries. Apex is far from alone: Goldman Sachs Alternatives backs Sila Services, Blackstone backs Champions Group, Leonard Green backs Wrench Group, and Bain Capital with Mubadala backs Service Logic. Sponsors closed a record number of HVAC deals in 2024, and add-on activity kept climbing into 2025, as documented in S&P Global Market Intelligence's reporting on the industry's appetite for add-ons.

Accounting: Private Equity's Newest Frontier

The most surprising recent frontier is public accounting, a profession that had never seen outside ownership at scale. In 2024, Hellman & Friedman and Valeas Capital Partners bought a majority stake in Baker Tilly for around $1 billion, the largest private equity investment in the US accounting profession at the time. Baker Tilly then agreed to combine with Moss Adams to form one of the six largest US CPA firms. Separately, New Mountain Capital took a majority stake in Grant Thornton in 2024, having earlier backed Citrin Cooperman. The pace has only accelerated: annual private equity deal volume in the sector climbed from roughly two dozen transactions in 2023 to more than 100 in 2025, and about a third of the 30 largest US accounting firms now carry private equity backing. This roll-up is early, though: most of the exits are still to come, which is exactly why the strategy is being debated so loudly.

These are far from the only examples. Dental support organizations, healthcare physician practices across specialties, waste management (where regional route density and landfill access create real consolidation benefits), and IT managed services all run on the same logic. What unites them is fragmentation plus recurring revenue plus a back office that can be centralized. When deciding whether a target fits, sponsors apply criteria similar to those in our guide on what makes a good LBO candidate, with the added requirement that the surrounding market has plenty of acquirable competitors.

A roll-up runs on a recognizable sequence. Each stage feeds the next, and the discipline of moving through them in order is often what separates a successful program from a sprawling, unintegrated mess.

The exit stage is where the arbitrage is finally realized, and the menu of options matters. A platform large enough can be sold to a strategic acquirer, taken public, or, very commonly, sold to a bigger private equity firm in a secondary buyout that starts the cycle again at greater scale. Our breakdown of a secondary buyout versus a strategic sale or IPO covers how sponsors choose between these paths.

Build the foundations first: Practice the technical and behavioral questions that come up in private equity recruiting, from LBO mechanics to deal walkthroughs, with our iOS app and its library of 1,000+ interview questions.

For all the elegance of the arbitrage math, roll-ups fail often, and the failure modes are predictable. Anyone discussing the strategy seriously, in an interview or otherwise, should be able to name the risks as fluently as the rewards.

Integration Failure

The most common failure is integration. The arbitrage assumes the acquired companies actually become one business. In practice, merging dozens of owner-operated companies with different systems, cultures, and customer relationships is brutally hard. Key employees leave, customers churn during the transition, software does not talk to each other, and the promised synergies never fully arrive. Academic and practitioner research consistently finds that a large share of acquisitions fail to deliver their expected value, with integration and culture cited as the usual culprits, a theme explored in Knowledge at Wharton's work on why M&A deals fail.

Overpaying for Add-Ons

The arbitrage only exists if the add-ons stay cheap. When a sector gets crowded with consolidators, entry multiples climb, and the spread between what you pay and what you can exit at narrows until the thesis stops working. The veterinary land grab, where practice multiples were bid from a few times earnings up into the double digits, is the cautionary case.

Over-Leverage and Rate Risk

Roll-ups are debt-funded and acquisitive, which means a lot of borrowing. When rates rise or earnings stumble, the interest burden can overwhelm cash flow, especially if synergies are slow to materialize. The era of nearly free debt that supercharged early roll-ups is gone, and programs underwritten on cheap financing have had to be repriced.

Too Much, Too Fast

There is also an operational version of biting off more than you can chew. A sponsor that races to buy thirty companies in two years without integrating them ends up with a holding company of thirty separate businesses rather than one platform, with none of the synergies and all of the overhead. This is precisely why the modern playbook, discussed below, emphasizes pausing to integrate.

Regulatory and Antitrust Scrutiny

As roll-ups consolidate entire local markets, regulators have started to push back. The clearest example is healthcare: the Federal Trade Commission sued U.S. Anesthesia Partners and its sponsor Welsh Carson, alleging the firm rolled up nearly every large anesthesia practice in Texas to raise prices. Welsh Carson was dismissed from the federal case on procedural grounds in 2024, but the FTC pressed on and reached a consent order in 2025 that limited the firm's involvement and required notice of future acquisitions, as detailed in the FTC's own announcement of the settlement. Regulators have signaled that serial acquisitions that individually fly under merger-review thresholds but collectively create local dominance are squarely on their radar.

The roll-up of 2026 does not look like the roll-up of 2018, and good candidates should be able to speak to how the strategy has matured. Three shifts stand out.

Fewer, Larger Add-Ons

The first shift is toward fewer and larger add-ons. Rather than acquiring fifteen tiny companies at $3 million of EBITDA each, more sponsors now favor a handful of larger add-ons, say three at $15 million each. Larger targets are better run, easier to integrate, and move the needle without multiplying complexity.

Integrate Before You Accelerate

The second shift is the discipline to integrate before you accelerate. Many programs now deliberately pause add-on activity, often around the eighteen-month mark, to fully absorb what they have already bought before resuming. The lesson of the last cycle was that unintegrated scale is not real scale.

Operational Value Over Financial Engineering

The third shift puts operational value ahead of financial engineering. With multiple expansion and cheap leverage no longer doing the heavy lifting, the firms winning at buy-and-build are the ones that genuinely improve the businesses they buy: better pricing, better technology, better management. The arbitrage still matters, but it is increasingly the floor of the return rather than the whole story.

Buy-and-build is a favorite topic in private equity interviews and increasingly in investment banking ones too, because it tests whether you understand value creation rather than just mechanics. Expect to be asked to explain multiple arbitrage, to define the difference between a platform and an add-on, and possibly to walk through a simple paper example of the math.

The Technical Questions

A common technical prompt is some version of "why would a sponsor pay 8x for the platform but only 5x for the add-ons?" The answer ties together everything above: the platform is larger, better managed, and provides the infrastructure and multiple, so it commands a premium, while the add-ons are sub-scale with few other buyers and get re-rated to the platform's multiple once integrated. If you can then connect this to how the returns compound, referencing metrics like IRR, MOIC, and cash-on-cash, you will stand out.

Get the complete framework: Download our comprehensive PDF covering every major technical concept and deal framework, including value creation and LBO analysis, in the IB Interview Guide.

The Deal Discussion

Behavioral and deal-discussion rounds increasingly touch on roll-ups too. If you can intelligently discuss a real consolidation story, naming the platform, a few add-ons, and the exit, as with the AssuredPartners or Inspire Brands examples above, you demonstrate that you actually follow the industry. For candidates targeting the buy-side, our guide on the path from investment banking to private equity covers how to position this kind of knowledge in recruiting.

The roll-up has become the defining private equity strategy of the era for a simple reason: it works in a world where cheap debt and rising multiples can no longer be counted on to deliver returns by themselves. By buying fragmented earnings cheaply, combining them into something larger and better run, and selling the whole at a premium, sponsors can create value through their own effort rather than market tailwinds. That is why add-ons now dominate the deal count and why national platforms keep emerging in industries that, a generation ago, were nothing but local family businesses.

But the math only works in practice if the discipline holds. Buy the add-ons too richly and the arbitrage vanishes. Skip the integration and the synergies never arrive. Pile on too much debt and a rate move can sink the whole program. The best sponsors treat buy-and-build not as a financial trick but as an operating challenge, and the gap between them and the rest has only widened. For anyone heading into private equity or banking, understanding both the elegance and the fragility of the roll-up is no longer optional. It is one of the central stories of how value gets created in the industry today.